Thus, in normal conditions, SETD7 targets HIF-1α for degradation operating as a tumour suppressor, but in oxidative stress, SETD7 exerts tumour-promoting effects by maintaining redox homeostasis to protect cancer cells from apoptosis (Figure 8c). Here, HIF1A is linked to neoplasm.